These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22722711)

  • 21. Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment.
    Holan V; Hermankova B; Bohacova P; Kossl J; Chudickova M; Hajkova M; Krulova M; Zajicova A; Javorkova E
    Stem Cell Rev Rep; 2016 Dec; 12(6):654-663. PubMed ID: 27665290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-gamma-induced bacteriostasis but does not abrogate toxoplasmastasis.
    MacKenzie CR; Langen R; Takikawa O; Däubener W
    Eur J Immunol; 1999 Oct; 29(10):3254-61. PubMed ID: 10540337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indoleamine 2,3-dioxygenase expression and regulation in chronic periodontitis.
    Nisapakultorn K; Makrudthong J; Sa-Ard-Iam N; Rerkyen P; Mahanonda R; Takikawa O
    J Periodontol; 2009 Jan; 80(1):114-21. PubMed ID: 19228097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells.
    Mohib K; Guan Q; Diao H; Du C; Jevnikar AM
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F801-12. PubMed ID: 17609291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).
    Croitoru-Lamoury J; Lamoury FM; Caristo M; Suzuki K; Walker D; Takikawa O; Taylor R; Brew BJ
    PLoS One; 2011 Feb; 6(2):e14698. PubMed ID: 21359206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
    Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
    Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoter.
    Rovira Gonzalez YI; Lynch PJ; Thompson EE; Stultz BG; Hursh DA
    Cytotherapy; 2016 Sep; 18(9):1114-28. PubMed ID: 27421739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells.
    Nahomi RB; Palmer A; Green KM; Fort PE; Nagaraj RH
    Biochim Biophys Acta; 2014 Feb; 1842(2):164-74. PubMed ID: 24252613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indoleamine 2, 3-Dioxgenase Transfected Mesenchymal Stem Cells Induce Kidney Allograft Tolerance by Increasing the Production and Function of Regulatory T Cells.
    He Y; Zhou S; Liu H; Shen B; Zhao H; Peng K; Wu X
    Transplantation; 2015 Sep; 99(9):1829-38. PubMed ID: 26308414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of indoleamine 2,3-dioxygenase (IDO) enzymatic activity contributes to interferon-gamma induced apoptosis and death receptor 5 expression in human non-small cell lung cancer cells.
    Chung TW; Tan KT; Chan HL; Lai MD; Yen MC; Li YR; Lin SH; Lin CC
    Asian Pac J Cancer Prev; 2014; 15(18):7995-8001. PubMed ID: 25292102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.
    Bonanno G; Mariotti A; Procoli A; Folgiero V; Natale D; De Rosa L; Majolino I; Novarese L; Rocci A; Gambella M; Ciciarello M; Scambia G; Palumbo A; Locatelli F; De Cristofaro R; Rutella S
    J Transl Med; 2012 Dec; 10():247. PubMed ID: 23232072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects.
    Müller A; Heseler K; Schmidt SK; Spekker K; Mackenzie CR; Däubener W
    J Cell Mol Med; 2009 Jun; 13(6):1125-35. PubMed ID: 19602041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.
    Yuan W; Collado-Hidalgo A; Yufit T; Taylor M; Varga J
    J Cell Physiol; 1998 Oct; 177(1):174-86. PubMed ID: 9731757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy. Laboratory investigation.
    Miyazaki T; Moritake K; Yamada K; Hara N; Osago H; Shibata T; Akiyama Y; Tsuchiya M
    J Neurosurg; 2009 Aug; 111(2):230-7. PubMed ID: 19199463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation.
    Heseler K; Spekker K; Schmidt SK; MacKenzie CR; Däubener W
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):273-81. PubMed ID: 18205804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.
    Hwang SL; Chung NP; Chan JK; Lin CL
    Cell Res; 2005 Mar; 15(3):167-75. PubMed ID: 15780178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting indoleamine 2,3-dioxygenase (IDO) to counteract tumour-induced immune dysfunction: from biochemistry to clinical development.
    Rutella S; Bonanno G; De Cristofaro R
    Endocr Metab Immune Disord Drug Targets; 2009 Jun; 9(2):151-77. PubMed ID: 19519465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts.
    Rödel J; Groh A; Hartmann M; Schmidt KH; Lehmann M; Lungershausen W; Straube E
    Med Microbiol Immunol; 1999 May; 187(4):205-12. PubMed ID: 10363677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
    Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-γ enhances the immunosuppressive ability of canine bone marrow-derived mesenchymal stem cells by activating the TLR3-dependent IDO/kynurenine pathway.
    Deng J; Li D; Huang X; Li W; Zhao F; Gu C; Shen L; Cao S; Ren Z; Zuo Z; Deng J; Yu S
    Mol Biol Rep; 2022 Sep; 49(9):8337-8347. PubMed ID: 35690960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.